INNOVENTIS PHARMA: what changed
What changed
INNOVENTIS PHARMA
NACE 46.450, Wholesale of perfume and cosmetics
filed annual accounts (NBB)
Net result for the year
€1,561
2024 · €4,105-€2,544
Equity
€396,169
2024 · €394,608+€1,561
Cash
€91,160
2024 · €114,058-€22,898
Balance sheet total
€1.7m
2024 · €1.6m+€74,496
Largest movements
Assets
- Stocks and contracts -€166,171
down €166,171 (-17.5%), from €951,161 to €784,990
- Tangible fixed assets +€148,551
up €148,551 (+75.2%), from €197,658 to €346,209
of which Leasing and similar rights: +€92,700
- Receivables within one year +€107,914
up €107,914 (+46.8%), from €230,353 to €338,267
of which Trade receivables: +€67,568
- Cash -€22,898
down €22,898 (-20.1%), from €114,058 to €91,160
mainly Investment in fixed assets (net) (-€289,352) and Short-term financial debts (-€150,000)
Equity and liabilities
- Short-term financial debts -€150,000
no longer reported in 2025 (was €150,000)
- Other debts +€149,924
up €149,924 (+22.0%), from €680,684 to €830,608
- Debts after one year +€73,305
up €73,305 (+1,705%), from €4,299 to €77,604
- Advances received -€34,536
no longer reported in 2025 (was €34,536)
- Current portion of long-term debt +€24,774
up €24,774 (+426%), from €5,816 to €30,590
Income statement
- Gross operating margin +€91,803
up €91,803 (+15.4%), from €597,719 to €689,522
- Staff costs +€77,000
up €77,000 (+16.5%), from €466,111 to €543,111
- Depreciation +€9,949
up €9,949 (+8.2%), from €121,620 to €131,569
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€4,105
Gross operating margin
+€91,803
Staff costs
-€77,000
Depreciation
-€9,949
Other operating charges
-€2,279
Other operating items
+€180
Financial income
+€32
Financial charges
-€5,331
Result 2025
€1,561
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€318,375
Investment
-€289,352
Financing
-€51,921
Cash 2024
€114,058
From operations (derived)
+€318,375
Net result for the year
+€1,561
Depreciation
+€131,569
Stocks and contracts
+€166,171
Receivables within one year
-€107,914
Deferred charges and accrued income
+€2,132
Trade debts
+€5,109
Tax, wage and social debts
+€4,359
Advances received
-€34,536
Other debts
+€149,924
Investment (derived)
-€289,352
Investment in fixed assets (net)
-€289,352
Financing
-€51,921
Debts after one year
+€73,305
Current portion of long-term debt
+€24,774
Short-term financial debts
-€150,000
Cash 2025
€91,160
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,583,704 | €1,658,200 | +€74,496 | +4.7% |
| Formation expenses | 20 | €2,473 | €1,868 | -€605 | -24.5% |
| Fixed assets | 21/28 | €283,527 | €441,915 | +€158,388 | +55.9% |
| Intangible fixed assets | 21 | €85,869 | €95,706 | +€9,837 | +11.5% |
| Tangible fixed assets | 22/27 | €197,658 | €346,209 | +€148,551 | +75.2% |
| Plant, machinery and equipment | 23 | €31,376 | €47,283 | +€15,907 | +50.7% |
| Furniture and vehicles | 24 | €15,856 | €15,814 | -€42 | -0.3% |
| Leasing and similar rights | 25 | €16,561 | €109,261 | +€92,700 | +560% |
| Other tangible fixed assets | 26 | €133,865 | €173,851 | +€39,986 | +29.9% |
| Current assets | 29/58 | €1,297,704 | €1,214,417 | -€83,287 | -6.4% |
| Stocks and contracts in progress | 3 | €951,161 | €784,990 | -€166,171 | -17.5% |
| Stocks | 30/36 | €951,161 | €784,990 | -€166,171 | -17.5% |
| Amounts receivable within one year | 40/41 | €230,353 | €338,267 | +€107,914 | +46.8% |
| Trade receivables | 40 | €215,470 | €283,038 | +€67,568 | +31.4% |
| Other amounts receivable | 41 | €14,883 | €55,229 | +€40,346 | +271% |
| Cash at bank and in hand | 54/58 | €114,058 | €91,160 | -€22,898 | -20.1% |
| Deferred charges and accrued income | 490/1 | €2,132 | - | -€2,132 | |
| Total equity and liabilities | 10/49 | €1,583,704 | €1,658,200 | +€74,496 | +4.7% |
| Equity | 10/15 | €394,608 | €396,169 | +€1,561 | +0.4% |
| Contributions | 10/11 | €561,500 | €561,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€166,892 | -€165,331 | +€1,561 | +0.9% |
| Amounts payable | 17/49 | €1,189,096 | €1,262,031 | +€72,935 | +6.1% |
| Amounts payable after more than one year | 17 | €4,299 | €77,604 | +€73,305 | +1,705% |
| Financial debts | 170/4 | €4,299 | €77,604 | +€73,305 | +1,705% |
| Amounts payable within one year | 42/48 | €1,184,797 | €1,184,427 | -€370 | 0.0% |
| Current portion of amounts payable after more than one year | 42 | €5,816 | €30,590 | +€24,774 | +426% |
| Financial debts | 43 | €150,000 | - | -€150,000 | |
| Credit institutions | 430/8 | €150,000 | - | -€150,000 | |
| Trade debts | 44 | €193,428 | €198,537 | +€5,109 | +2.6% |
| Suppliers | 440/4 | €193,428 | €198,537 | +€5,109 | +2.6% |
| Advances received on contracts in progress | 46 | €34,536 | - | -€34,536 | |
| Taxes, remuneration and social security | 45 | €120,333 | €124,692 | +€4,359 | +3.6% |
| Taxes | 450/3 | €19,391 | - | -€19,391 | |
| Remuneration and social security | 454/9 | €100,942 | €124,692 | +€23,750 | +23.5% |
| Other amounts payable | 47/48 | €680,684 | €830,608 | +€149,924 | +22.0% |
| Non-recurring operating income | 76A | €134,872 | €3,558 | -€131,314 | -97.4% |
| Remuneration, social security and pensions | 62 | €466,111 | €543,111 | +€77,000 | +16.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €121,620 | €131,569 | +€9,949 | +8.2% |
| Other operating charges | 640/8 | €3,732 | €6,011 | +€2,279 | +61.1% |
| Non-recurring operating charges | 66A | €180 | - | -€180 | |
| Gross operating margin | 9900 | €597,719 | €689,522 | +€91,803 | +15.4% |
| Operating profit (loss) | 9901 | €6,076 | €8,831 | +€2,755 | +45.3% |
| Financial income | 75/76B | €35 | €67 | +€32 | +91.4% |
| Recurring financial income | 75 | €34 | €67 | +€33 | +97.1% |
| Non-recurring financial income | 76B | €1 | - | -€1 | |
| Financial charges | 65/66B | €2,006 | €7,337 | +€5,331 | +266% |
| Recurring financial charges | 65 | €2,006 | €7,337 | +€5,331 | +266% |
| Profit (loss) for the period before taxes | 9903 | €4,105 | €1,561 | -€2,544 | -62.0% |
| Profit (loss) for the period | 9904 | €4,105 | €1,561 | -€2,544 | -62.0% |
| Profit (loss) for the period to be appropriated | 9905 | €4,105 | €1,561 | -€2,544 | -62.0% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.